Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jan 21, 2008; 14(3): 474-478
Published online Jan 21, 2008. doi: 10.3748/wjg.14.474
Published online Jan 21, 2008. doi: 10.3748/wjg.14.474
Table 1 Baseline in the two groups
| Baseline | Late treatment group (n = 38) | Early treatment group (n = 38) |
| Sex (Male/Female) | 21/17 | 22/16 |
| Age (mean ± SD, yr) | 47.5 ± 12.6 (22-76) | 46.9 ± 12.8 (27-74) |
| Etiology, n (%) | ||
| Gallstones | 20 (52.6) | 16 (42.1) |
| Alcohol abuse | 2 (5.3) | 7 (18.7) |
| Hyperlipidemia | 7 (18.4) | 9 (23.7) |
| Idiopathic | 9 (23.7) | 6 (15.8) |
| 48-h Ranson score (mean ± SD) | 4.5 ± 1.7 | 4.8 ± 1.6 |
| 24-h APACHE II score (mean ± SD) | 10.8 ± 3.5 | 10.2 ± 3.1 |
| CT score (mean ± SD) | 5.8 ± 2.3 | 5.9 ± 2.4 |
- Citation: Xue P, Deng LH, Xia Q, Zhang ZD, Hu WM, Yang XN, Song B, Huang ZW. Impact of alanyl-glutamine dipeptide on severe acute pancreatitis in early stage. World J Gastroenterol 2008; 14(3): 474-478
- URL: https://www.wjgnet.com/1007-9327/full/v14/i3/474.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.474